Left atrial appendage occlusion vs continuation of oral anticoagulation therapy alone is linked to reduced ischemic stroke risk in select patients with nonvalvular AF.
The FDA has granted Fast Track designation to PP-007 (PEGylated carboxyhemoglobin, bovine) for the treatment of acute ischemic stroke.
Patients with cryptogenic stroke treated with routine transcatheter patent foramen ovale closure have increased 4-year stroke risk.